Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity

Metformin is not currently used for weight loss or diabetes prevention because it lacks an FDA indication for obesity and/or pre-diabetes treatment. Based on the evidence, metformin has been shown to decrease the incidence of type 2 diabetes, and compares favorably to other weight-loss medications i...

Full description

Saved in:
Bibliographic Details
Published in:Current atherosclerosis reports 2016-04, Vol.18 (4), p.16-16, Article 16
Main Authors: Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., Aronne, L. J.
Format: Article
Language:English
Subjects:
Angiology
Anti-Obesity Agents - adverse effects
Anti-Obesity Agents - therapeutic use
Cardiology
Cardiovascular Diseases
Diabetes Mellitus - prevention & control
Humans
Medicine
Medicine & Public Health
Metformin - adverse effects
Metformin - therapeutic use
Neoplasms
Nonstatin Drugs (E. deGoma
Obesity - drug therapy
Obesity - therapy
Section Editor
Topical Collection on Nonstatin Drugs
Weight Loss - drug effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metformin is not currently used for weight loss or diabetes prevention because it lacks an FDA indication for obesity and/or pre-diabetes treatment. Based on the evidence, metformin has been shown to decrease the incidence of type 2 diabetes, and compares favorably to other weight-loss medications in terms of efficacy as well as safety. Thus, metformin should be considered for a treatment indication in patients with these conditions.
ISSN:1523-3804
1534-6242
DOI:10.1007/s11883-016-0568-3